Literature DB >> 13400844

SYMPOSIUM on anti-tumour agents: cytostatic agents.

.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS

Mesh：

Substances：

Year:  1957        PMID： 13400844      PMCID： PMC1888987     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  14 in total

1.  The toxic effects of 6-mercaptopurine and related compounds.

Authors:  F S PHILIPS; S S STERNBERG; S HAMILTON; D A CLARKE
Journal:  Ann N Y Acad Sci       Date:  1954-12-06       Impact factor: 5.691

2.  Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia.

Authors:  A S WEISBERGER; L G SUHRLAND
Journal:  Blood       Date:  1956-01       Impact factor: 22.113

3.  Synergism in cancer therapy.

Authors:  E BOYLAND
Journal:  Proc R Soc Med       Date:  1956-11

4.  Reduction of cytotoxic azo compounds by hydrazine and by the xanthine oxidase-xanthine system.

Authors:  W C ROSS; G P WARWICK
Journal:  Nature       Date:  1955-08-13       Impact factor: 49.962

5.  Studies on the anti-tumour activity of p-di-(2-chloroethyl) aminophenylalanine (sarcolysine).

Authors:  L F LARIONOV; E N SHKODINSKAJA; V I TROOSHEIKINA; A S KHOKHLOV; O S VASINA; M A NOVIKOVA
Journal:  Lancet       Date:  1955-07-23       Impact factor: 79.321

6.  Selectivity of enzyme-activated nitrogen mustards.

Authors:  P HEBBORN; J F DANIELLI
Journal:  Nature       Date:  1956-01-07       Impact factor: 49.962

7.  Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

Authors:  A HADDOW; G M TIMMIS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

8.  A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.

Authors:  W B MATTHEWS
Journal:  Lancet       Date:  1950-05-13       Impact factor: 79.321

9.  A comparison of the retardation of Sarcoma 180 by SK 1424, 3-Bis (beta-chloroethyl) aminomethyl-4-methoxymethyl-5-hydroxy-6-methyl-pyridine with that by HN2, Methylbis (beta-chloroethyl) amine.

Authors:  C C STOCK; S BUCKLEY; K SUGIURA; C P RHOADS
Journal:  Cancer Res       Date:  1951-06       Impact factor: 12.701

10.  Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.

Authors:  R R ELLISON; D A KARNOFSKY; S S STERNBERG; M L MURPHY; J H BURCHENAL
Journal:  Cancer       Date:  1954-07       Impact factor: 6.860
View more
  1 in total

1.  Endomyocardial fibrosis in the Ceylonese.

Authors:  N NAGARATNAM; R V DISSANAYAKE
Journal:  Br Heart J       Date:  1959-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.